SEARCH

SEARCH BY CITATION

References

  • Adjuik M, Agnamey P, Babiker A et al. (2002) Amodiaquine–artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359, 13651372.
  • Barennes H, Nagot N, Valea I et al. (2004) A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. Tropical Medicine and International Health 9, 438444.
  • Bousema JT, Gouagna LC, Drakeley CJ et al. (2004) Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malaria Journal 17, 318.
  • Van Den Broek I, Amsalu R, Balasegaram M et al. (2005) Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. Malaria Journal 4, 14.
  • Checchi F, Roddy P, Kamaras S et al. (2005) Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine–pyrimethamine and amodiaquine. Tropical Medicine and International Health 10, 146153.
  • Coene J (1993) Malaria in urban and rural Kinshasa: the entomological input. Medical and Veterinary Entomology 7, 127137.
  • Cohuet S, Bonnet M, Van Herp M, Van Overmeir C, D'Allessandro U & Guthmann JP (2006) Short report: Molecular markers associated with Plasmodium falciparum resistance to sulfadoxine–pyrimethamine in the Democratic Republic of Congo. The American Journal of Tropical Medicine and Hygiene 75, 152154.
  • Delacolette C, Embonga B & Malengreau M (1983) Response to chloroquine of infections with Plasmodium falciparum in the Kivu region of Zaire. Preliminary observations. Annales de la Société Belge de Medecine Tropicale 63, 171173.
  • East African Network for Monitoring Antimalarial Treatment (EANMAT) (2004) The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Tropical Medicine and International Health 8, 860867.
  • Fogg C, Bagunirwe F, Piola P et al. (2004) Adherence to a six-dose regimen of artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. The American Journal of Tropical Medicine and Hygiene 71, 525530.
  • Global Fund (2004) Global fund commitments to improve international malaria treatment, reflecting conclusions of a February 24 consultation of the Global Fund, WHO and members of the scientific community. http://www.theglobalfund.org/pdf/annex_a_globalfund_commitments1.pdf .
  • Grandesso F, Hagerman A, Kamara S et al. (2006) Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 in Kailahun, Sierra Leone. Tropical Medicine and International Health 11, 10171021.
  • Guthmann JP, Ampuero J, Fortes F et al. (2005) Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine–pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine–pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 485492.
  • Hamour S, Melaku Y, Keus K et al. (2005) Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine–pyrimethamine and artesunate plus amodiaquine combinations. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 548554.
  • Kazadi WM, Vong S, Burstein NM et al. (2003) Assessing the efficacy of chloroquine and sulfadoxine–pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. Tropical Medicine and International Health 8, 868875.
  • Kublin JG, Dzinjalamala FK, Kamwendo DD et al. (2002) Molecular markers for failure of sulfadoxine–pyrimethamine and chlorproguanil–dapsone treatment of Plasmodium falciparum malaria. The Journal of Infectious Diseases 185, 380388.
  • Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ & Dorsey G (2003) Validation of a simplified method for using molecular markers to predict sulfadoxine–pyrimethamine treatment failure in African children with falciparum malaria. The American Journal Tropical Medicine and Hygiene 69, 247252.
  • Malenga G, Palmer A, Staedke S et al. (2005) Antimalarial treatment with artemisinin combination therapy in Africa. British Medical Journal 331, 706707.
  • Martensson A, Stromberg J, Sisowath C et al. (2005) Efficacy of artesunate plus amodiaquine versus that of artemether–lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clinical Infectious Diseases 41, 10791086.
  • Mutabingwa TK, Anthony D, Heller A et al. (2005) Amodiaquine alone, amodiaquine + sulfadoxine–pyrimethamine, amodiaquine + artesunate for outpatient treatment of malaria in Tanzanian children: a four-armed randomised effectiveness trial. Lancet 365, 14741480.
  • Nosten F & Brasseur P (2002) Combination therapy for malaria: the way forward? Drugs 62, 13151329.
  • Olliaro P, Nevill C, LeBras J et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 11961201.
  • Omar SA, Mens PF, Schoone GJ et al. (2005) Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine–pyrimethamine treatment of uncomplicated malaria. Experimental Parasitology 110, 7379.
  • Pearce R, Drakeley C, Chandramohan D et al. (2003) Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrobial Agents and Chemotherapy 47, 13471354.
  • Piola P, Fogg C, Bajunirwe F et al. (2005) Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 365, 14671473.
  • Plowe CV, Kublin JG & Doumbo OK (1998) Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resistance Updates 1, 389396.
  • Programme National de Lutte contre le Paludisme (PNLP) (2002) Faire Reculer le Paludisme, Plan Stratégique: 2002–2006. Ministère de Santé, RDC.
  • Price R, Nosten F, Luxemburger C et al. (1996) Effect of artemisinin derivatives on malaria transmissibility. Lancet 347, 16541658.
  • Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S & White NJ (2004) Activities of artesunate and primaquine aganist asexual and sexual stage parasites in falciparum malaria. Antimicrobial Agents and Chemotherapy 48, 13291334.
  • Rwagacondo CE, Karema C, Mugisha V et al. (2004) Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Tropical Medicine and International Health 9, 10911098.
  • Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369374.
  • Sowumni A & Fateye BA (2003) Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Tropical Medicine International Health 8, 783792.
  • Staedke SG, Mpimbaza A, Kamya MR, Nzarubara BK, Dorsey G & Rosenthal PJ (2004) Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet 364, 19501957.
  • Whitty C, Allan R, Wiseman V et al. (2004) Averting a malaria disaster in Africa – where does the buck stop? Bulletin of the World Health Organization 82, 381384.
  • WHO (2003) Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. (WHO/HTM/RBM/2003.50), WHO, Geneva, Switzerland.
  • WHO (2005a) Susceptibility of Plasmodium falciparum to Antimalarial Drugs, Report on Global Monitoring 1996–2004. (WHO/HTM/MAL/2005.1103), WHO, Geneva, Switzerland.
  • WHO (2005b) World Health Report: 2005: Make Every Mother and Child Count. WHO, Geneva, Switzerland.
  • WHO (2006) Facts on ACTs (artemisinin-based combination therapies), January 2006 update. http://www.rbm.who.int .
  • Yeka A, Banek K, Bakyaita N et al. (2005) Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Medicine 2, e190. (Epub 26 July 2005).